Gilead Sciences quarterly revenue rises 6.8% to $8.30 billion
Gilead Sciences' revenue growth is slowing. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
173.00▲ +4.46%
Latest · 2026-10-30
Gilead Sciences' revenue growth is slowing. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
2026-10-30